KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Operating Leases (2021 - 2025)

Bionano Genomics (BNGO) has disclosed Operating Leases for 5 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly Operating Leases rose 1616.55% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, up 1616.55% year-over-year, with the annual reading at $2.5 million for FY2025, 1616.55% up from the prior year.
  • Operating Leases hit $2.5 million in Q4 2025 for Bionano Genomics, down from $3.6 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $6.5 million in Q3 2022 to a low of $145000.0 in Q4 2024.
  • Historically, Operating Leases has averaged $4.3 million across 5 years, with a median of $4.6 million in 2023.
  • Biggest five-year swings in Operating Leases: tumbled 95.96% in 2024 and later skyrocketed 1616.55% in 2025.
  • Year by year, Operating Leases stood at $5.3 million in 2021, then grew by 4.08% to $5.5 million in 2022, then crashed by 34.77% to $3.6 million in 2023, then crashed by 95.96% to $145000.0 in 2024, then surged by 1616.55% to $2.5 million in 2025.
  • Business Quant data shows Operating Leases for BNGO at $2.5 million in Q4 2025, $3.6 million in Q3 2025, and $4.1 million in Q2 2025.